Monster Energy Company v Ox Group Global Pty Limited (2017) NZHC 2393
Monster Energy Company (“Monster”) appealed against a decision of the NZ Trade Marks Office to dismiss its opposition to trade mark application No. 998778 for the following mark in...
Monster Energy Company (“Monster”) appealed against a decision of the NZ Trade Marks Office to dismiss its opposition to...
Read More
Red Bull GmbH v Bullsone Co., Ltd [2017] ATMO 121 (19 October 2017)
Bullsone applied to register the below trade mark covering a range of goods in Classes 1 (chemical additives), 3 (paint preparations), 4 (oils and lubricants), 5 (deodorants and insect...
Bullsone applied to register the below trade mark covering a range of goods in Classes 1 (chemical additives), 3...
Read More
Improved IPO website in Papua New Guinea (PNG) unveiled
Securing protection for your intellectual property in the South Pacific can often be both challenging and time-consuming.  If registration is available (which is not always the case), the registration...
Securing protection for your intellectual property in the South Pacific can often be both challenging and time-consuming.  If registration...
Read More
Australia Update: IP Australia announces a reduction in PCT fees
Following the directives adopted by the PCT Assembly, IP Australia has announced updated fees for PCT applications. The updated fees will be published in the Australian Official Journal of...
Following the directives adopted by the PCT Assembly, IP Australia has announced updated fees for PCT applications. The updated...
Read More
Pfizer succeeds in Full Federal Court appeal and will now receive preliminary discovery regarding possible infringement of biological medicine process patents
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd  FCA 285, in which...
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals...
Read More
The Patent Office provides clarity regarding enablement of polypeptide claims
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to perform an invention over the entire scope of the claims...
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to...
Read More
Australia Update: Swiss style claims and patent term extension
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In this regard, a patent term extension (PTE) of up to...
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In...
Read More
Missed an Australian patent deadline? Here’s what to do
In some jurisdictions, patent prosecution deadlines and deadlines for payment of maintenance fees (sometimes called renewal fees) are a “life and death” issue and missing a deadline can be...
In some jurisdictions, patent prosecution deadlines and deadlines for payment of maintenance fees (sometimes called renewal fees) are a...
Read More

Contact our Expert Team

Contact Us
Contact Us